Raymond James Financial Inc. Makes New Investment in Healthpeak Properties, Inc. (NYSE:DOC)

Raymond James Financial Inc. acquired a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,112,244 shares of the real estate investment trust’s stock, valued at approximately $22,545,000. Raymond James Financial Inc. owned about 0.16% of Healthpeak Properties at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. State Street Corp bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth $1,093,576,000. Geode Capital Management LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth $403,898,000. Principal Financial Group Inc. grew its stake in shares of Healthpeak Properties by 2,113.5% in the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after acquiring an additional 17,314,572 shares in the last quarter. Charles Schwab Investment Management Inc. bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth $230,988,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth $175,697,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

Shares of NYSE:DOC opened at $20.45 on Friday. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The firm has a market capitalization of $14.30 billion, a PE ratio of 58.42, a P/E/G ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a twelve month low of $17.05 and a twelve month high of $23.26. The company has a 50-day moving average price of $20.21 and a two-hundred day moving average price of $21.23.

Healthpeak Properties Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were given a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a yield of 5.97%. The ex-dividend date of this dividend was Friday, February 14th. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. Healthpeak Properties’s dividend payout ratio (DPR) is currently 348.57%.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Scotiabank reduced their target price on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a research note on Friday, February 28th. StockNews.com upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Thursday. Wedbush reduced their price target on shares of Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, February 14th. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target for the company in a research report on Wednesday, January 15th. Finally, Mizuho reduced their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. Four analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and a consensus target price of $23.92.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.